Short Interest in GBank Financial Holdings Inc. (OTCMKTS:GBFH) Drops By 92.2%
by Doug Wharley · The Cerbat GemGBank Financial Holdings Inc. (OTCMKTS:GBFH – Get Free Report) saw a large drop in short interest in November. As of November 15th, there was short interest totalling 400 shares, a drop of 92.2% from the October 31st total of 5,100 shares. Based on an average daily volume of 32,500 shares, the short-interest ratio is currently 0.0 days.
GBank Financial Trading Down 1.2 %
GBank Financial stock traded down $0.40 during mid-day trading on Wednesday, hitting $33.10. 2,293 shares of the company’s stock were exchanged, compared to its average volume of 14,561. GBank Financial has a 1-year low of $12.86 and a 1-year high of $34.00. The stock has a 50 day moving average of $26.15 and a two-hundred day moving average of $20.67.
GBank Financial (OTCMKTS:GBFH – Get Free Report) last announced its quarterly earnings results on Tuesday, October 22nd. The company reported $0.37 EPS for the quarter, beating the consensus estimate of $0.30 by $0.07. The company had revenue of $16.12 million for the quarter, compared to analyst estimates of $15.30 million. On average, analysts forecast that GBank Financial will post 1.32 earnings per share for the current fiscal year.
About GBank Financial
GBank Financial Holdings Inc operates as a bank holding company for GBank that provides banking services to commercial and consumer customers in Nevada. The company offers business and personal checking and savings accounts. It also provides small business administration loans; commercial real estate, equipment, business term, and medical/professional loans; business lines of credit; accounts receivable/inventory financing services; and credit cards.
Featured Stories
- Five stocks we like better than GBank Financial
- Are Penny Stocks a Good Fit for Your Portfolio?
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Stock Average Calculator
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- 2 Generic Drug Stocks Ready to Surge in 2025